U.S. Healthtech Stock News

Ingredion (INGR) has secured a US$1.475b senior unsecured delayed draw term loan facility to support its proposed cash acquisition of Tate & Lyle, related debt refinancing, and associated transaction costs. See our latest analysis for Ingredion. Ingredion’s share price has softened in recent months, with a 30 day share price return of 6.63% lower and a year to date share price return down 13.74%, while the 1 year total shareholder return has declined 28.69%. This suggests recent M&A and...

In June 2026, NiSource Inc. reported that the Indiana Utility Regulatory Commission approved its agreements and power purchase deal supporting Amazon’s new data center developments in northern Indiana, along with new gas-fired generation and battery storage resources. The approved framework is structured so data center customers cover the cost of the required infrastructure, with NiSource expecting existing NIPSCO customers to share in about US$1.40 billion of projected savings and benefit...

In late June 2026, Choice Hotels International (NYSE: CHH) was removed from multiple Russell value and small-cap benchmarks while being added to the Russell 1000 Dynamic Index as part of annual index rebalancing. This broad reshuffle of index memberships can influence how quantitatively driven and benchmark-focused investors gain or reduce exposure to the stock, potentially altering liquidity and trading patterns. Next, we’ll examine how Choice Hotels’ shift out of several Russell value...

Biohaven has recently completed enrollment in its pivotal Phase 2/3 RISE3 trial of opakalim for refractory focal epilepsy and enrolled the first patient in a pivotal Phase 3 study of BHV-1300 for Graves' disease. Together, these milestones highlight Biohaven's push to advance a differentiated neurology and immunology pipeline, spanning next-generation Kv7 activators and first-in-class extracellular protein degraders. With these epilepsy and Graves' disease programs reaching critical clinical...

In June 2026, The Travelers Companies, Inc. announced TravelersLLM, a proprietary large language model built on millions of internal documents to enhance underwriting, research, and workflows across its property-casualty operations. The model’s consistent outperformance of commercial AI systems in extensive internal testing, along with its CIO 100 Award recognition, highlights how deeply embedded, domain-specific AI could reshape how Travelers harnesses its institutional knowledge. We’ll now...

Over the past two weeks, partners including Accenture, Cyberhill, Cognizant, Inspira, ID.me, Nametag, and Aria Systems have unveiled new AI‑powered solutions built on the ServiceNow AI Platform, spanning cybersecurity, biosurveillance, telecom monetization, identity verification, and public-sector benefits modernization. Together, these announcements reinforce ServiceNow’s role as an AI orchestration and governance layer embedded in critical workflows across government, telecom,...

Global financial stocks are back in the spotlight as new policy frameworks, regulatory shifts and inflation control efforts reshape expectations for stability and growth. For investors watching how large banks, insurers and diversified financial companies might respond to these changes, the current set of developments can signal both opportunity and risk. This article looks at three large cap financial stocks from the US, UK and Canada in our Financial Sector Stocks screener that appear...

The recent suspension of the US debt ceiling has taken some of the immediate stress out of the macro picture, easing default fears and supporting confidence across bonds and equities. For investors, it creates a cleaner backdrop to reassess exposure to companies tied closely to US government debt and capital markets. This article looks at 3 stocks from the Financial Sector Opportunities From US Debt Ceiling Suspension screener that are most directly exposed to this policy shift, and aims to...

In late June 2026, Gorilla Technology Group raised its Q2 2026 revenue outlook to at least US$44,000,000, citing accelerating AI infrastructure demand and stronger conversion of existing commercial commitments into revenue, implying very large year-on-year growth and more than 55% sequential improvement versus Q1 2026. This upgrade highlights how Gorilla’s execution on multi-region contracts and AI-focused solutions is starting to translate into materially higher near-term revenue...

In the past quarter, Silicon Motion Technology Corporation reported first-quarter 2026 results that significantly surpassed its own guidance and market expectations, alongside management projections for continued sequential revenue and margin expansion through 2026, supported by strong demand from AI and data center storage markets. An interesting angle is that this upbeat outlook coincides with both highly favorable analyst earnings revisions tied to new AI-focused products and a director...

Allegiant Travel (ALGT) has reshaped its balance sheet by issuing US$650 million of 7.125% Senior Secured Notes due 2031 and using much of the cash to retire earlier 2027 debt at 7.25%. See our latest analysis for Allegiant Travel. The debt refinancing headlines come as Allegiant Travel’s stock shows strong momentum, with a 30 day share price return of 28.37% and a 1 year total shareholder return of 101.47%, even though the 5 year total shareholder return is down 36.39%. If you are looking...

In late June 2026, GoTu Technology announced a new partnership with Henry Schein Dental Recruitment Services to integrate its workforce platform and expand access to temporary and permanent dental staffing solutions across Henry Schein’s customer base. This collaboration links a high-volume shift-filling platform with one of dentistry’s largest distribution and advisory networks, directly targeting the workforce shortages that have been straining practice operations and patient care. Next,...

Celldex Therapeutics (CLDX) has just been added to several Russell growth benchmarks, coinciding with updated long term Phase 2 data for barzolvolimab in angioedema, a combination that is drawing fresh attention to the stock. See our latest analysis for Celldex Therapeutics. The latest Russell index additions and the updated barzolvolimab data come after a strong period for Celldex Therapeutics, with a year to date share price return of 37.76% and a 1 year total shareholder return of 75.44%,...

On 27 June 2026, CBIZ, Inc. (NYSE: CBZ) was reclassified into multiple Russell value-oriented indices, including the Russell 2000 Value and Russell 3000 Value benchmarks, while being removed from several growth-focused indices. This shift in index inclusion highlights the market’s current view of CBIZ as more aligned with value characteristics, even as analysts continue to highlight its growth attributes and improving fundamentals. We’ll now examine how CBIZ’s shift into several Russell...

Kinder Morgan recently highlighted its growth plans at the Energy Infrastructure CEO and Investor Conference, where VP of Corporate Development Kevin Grahmann outlined a US$10.00 billion project backlog focused on long-haul natural gas infrastructure serving power, LNG, and industrial customers. The discussion underscored Kinder Morgan’s role in transporting about 40% of US natural gas consumption, emphasizing how its extensive pipeline network underpins long-term demand for its...

Index removals put CBL & Associates Properties in focus CBL & Associates Properties (CBL) has been removed from several Russell value indices, a mechanical shift that can prompt index-tracking funds to adjust positions and often brings the stock onto active investors' watchlists. See our latest analysis for CBL & Associates Properties. Despite the index removals, CBL & Associates Properties has seen firm momentum recently, with a 7 day share price return of 5.99% and a 90 day share price...

Index reshuffle puts fresh attention on Conagra Brands stock Conagra Brands (CAG) has just shifted index homes, leaving the S&P 500 and joining the S&P 600 and Russell small and mid cap benchmarks, a change that can alter how some funds hold the stock. For you as an investor, this kind of index move often matters less for day to day business performance than for how certain passive and rules based portfolios treat Conagra Brands. Inclusion in the S&P 600 and Russell small cap and value...

MongoDB has rolled out advanced AI focused Search, Vector Search, Hybrid Search, and Native Reranking powered by Voyage AI. These capabilities are now generally available across Atlas, Enterprise Advanced, and Community Edition. The launch extends AI retrieval and search to on premises, private cloud, and local environments, with a focus on compliance sensitive sectors. For investors tracking MongoDB, ticker NasdaqGM:MDB, this product launch comes with the stock trading around $335.9 and up...

Analyst upgrades and chip investment plans put Entegris in focus Entegris (ENTG) moved into the spotlight after analysts at Mizuho and UBS raised their outlook, citing stronger sentiment around semiconductor equipment as well as new spending plans from Samsung Electronics and SK Hynix. See our latest analysis for Entegris. Beyond the upgraded views from Mizuho and UBS, Entegris has also been featured in recent stock-picking pitches for its role in advanced nanochips. The stock’s momentum has...

Index removal puts JPMorgan Chase under the microscope JPMorgan Chase (JPM) was recently removed from the Russell 1000 Dynamic Index, a change that can alter how some index linked investors hold the stock and prompt closer attention to its capital plans. See our latest analysis for JPMorgan Chase. Short term, JPMorgan Chase has eased back slightly with a 7 day share price return of 2.04% and a 1 day move lower of 0.63%. However, the 30 day share price return of 9.36% and 90 day share price...

Interest rate headlines are back in focus as Federal Reserve Chairman Kevin Warsh steps onto the global stage, and that matters for how you think about growth stocks with bigger price swings. With markets weighing the chance of sharper rate hikes, softer private payrolls data, and a quieter Fed communication style, some higher growth companies may face fresh pressure while others could look more appealing. This article explains how those catalysts connect to interest-sensitive growth stories...

In the past six months, Nova reported strong quarterly results, underpinned by a 25.3% compounded annual revenue growth rate over five years and a 28.8% operating margin that outpaced many semiconductor peers. This combination of rapid top-line expansion and consistently high profitability has reinforced perceptions of Nova as an efficient, high-quality operator in an increasingly complex semiconductor landscape. Next, we’ll examine how this combination of rapid revenue expansion and high...

AGM update puts POET Technologies production ramp and spending plans in focus POET Technologies (POET) used its June 26 virtual Annual General Meeting to reaffirm that its optical engine production ramp is on schedule, with volume shipments targeted for the second half of 2026. For investors tracking the stock, the company also outlined plans to expand capacity to as many as 1 million units per month by the end of 2027, supported by recently raised equity capital and planned equipment...

In recent weeks, U.S. Bancorp has outlined plans to raise its quarterly common stock dividend by 3.8%, subject to board approval, while maintaining a stress capital buffer of 2.6% and capital ratios comfortably above regulatory minimums. Alongside this, the bank is reinforcing its fee-oriented growth efforts, including new leadership in healthcare payments, signaling an emphasis on capital strength and diversified revenue streams. With this planned dividend increase highlighting balance...